Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SSGI corrective action plan on premarket data integrity to be submitted to FDA within one month.

This article was originally published in The Gray Sheet

Executive Summary

SSGI TO SUBMIT CORRECTIVE PLAN FOR 510(k) DATA INTEGRITY DEFICIENCIES within one month, Chico, California-based Small Systems Group, Inc. says. The plan, which is required under FDA's application integrity policy (AIP), will outline steps the company will take to ensure the integrity of data in its premarket submissions to FDA. The agency placed SSGI under its AIP in July 1994 due to concerns about data in a May 1993 submission for the firm's Prowess 2000 software package for radiation therapy planning.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006530

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel